{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:17:34Z","timestamp":1792192654180,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1977,1,1]],"date-time":"1977-01-01T00:00:00Z","timestamp":220924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1977]]},"DOI":"10.1007\/bf00606415","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T03:46:29Z","timestamp":1101354389000},"page":"225-231","source":"Crossref","is-referenced-by-count":23,"title":["Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency"],"prefix":"10.1007","volume":"11","author":[{"given":"M.","family":"P\ufffdrez-Mateo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Erill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM197107292850506","volume":"285","author":"M. M. Reidenberg","year":"1971","unstructured":"Reidenberg, M. M., Odar-Cederl\u00f6f, I., Bahr, C. V., Borg\u00e5, O., Sj\u00f6qvist, F.: Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl. J. Med.285, 264?267 (1971)","journal-title":"New Engl. J. Med."},{"key":"CR2","first-page":"109","volume":"286","author":"M. Blum","year":"1972","unstructured":"Blum, M., Riegelman, S., Becker, C.F.: Altered protein binding of DPH in uremic plasma. New Engl. J. Med.286, 109 (1972)","journal-title":"New Engl. J. Med."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0773.1973.tb01488.x","volume":"32","author":"F. Andreasen","year":"1973","unstructured":"Andreasen, F.: Protein binding of drugs in plasma from patients with acute renal failure. Acta pharmacol. (Kbh.)32, 417?429 (1973)","journal-title":"Acta pharmacol."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0041-008X(73)90312-8","volume":"25","author":"D. S. Campion","year":"1973","unstructured":"Campion, D. S.: Decreased drug binding by serum albumin during renal failure. Toxicol. appl. Pharmacol.25, 391?397 (1973)","journal-title":"Toxicol. appl. Pharmacol."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1749-6632.1973.tb20474.x","volume":"226","author":"M. M. Reidenberg","year":"1973","unstructured":"Reidenberg, M. M., Affrime, M.: Influence of disease on binding of drugs to plasma proteins. Ann N. Y. Acad. Sci.226, 115?126 (1973)","journal-title":"Ann N. Y. Acad. Sci."},{"key":"CR6","first-page":"174","volume-title":"Effect of kidney disease on pharmacokinetics and drug response","author":"M. M. Reidenberg","year":"1970","unstructured":"Reidenberg, M. M.: Effect of kidney disease on pharmacokinetics and drug response. Proc. Fifth Int. Congress of Pharmacology Vol. 3, 174?181. Basel: Karger 1970"},{"key":"CR7","first-page":"423","volume-title":"Fluorescence in biology and medicine","author":"S. Udenfriend","year":"1962","unstructured":"Udenfriend, S.: Fluorescence in biology and medicine, p. 423. New York: Academic Press 1962"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/00365516309079786","volume":"15","author":"G. Cramer","year":"1963","unstructured":"Cramer, G.; Isaksson, B. S.: Quantitative determination of quinidine in plasma. Scand. J. clin. Lab. Invest.15, 553?556 (1963)","journal-title":"Scand. J. clin. Lab. Invest."},{"key":"CR9","volume-title":"Statistical methods","author":"G. W. Snedecor","year":"1967","unstructured":"Snedecor, G. W., Cochran, W. G.: Statistical methods. Ames, Iowa: Iowa State University Press 1967"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cpt196895561","volume":"9","author":"A. H. Anton","year":"1968","unstructured":"Anton, A. H.: The effect of disease, drugs and dilution on the binding of sulfonamides in human plasma. Clin. Pharmacol. Ther.9, 561?567 (1968)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR11","first-page":"707","volume":"11","author":"W. Scholtan","year":"1961","unstructured":"Scholtan, W.: Die Bindung der Langzeit-Sulfonamide an die Eiwei\u00dfk\u00f6rper des Serums. 2. Mitteilung. Arzneimittel-Forsch.11, 707?720 (1961)","journal-title":"Arzneimittel-Forsch."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01478662","volume":"42","author":"H. B\u00fcttner","year":"1964","unstructured":"B\u00fcttner, H., Portwich, F., Manzke, E., Staudt, N.: Zur Pharmakokinetik von Sulfonamiden unter pathologischen Bedingungen. Klin. Wschr.42, 103?108 (1964)","journal-title":"Klin. Wschr."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0954-6820.1937.tb16038.x","volume":"91","author":"M. C. Ehrstr\u00f6m","year":"1937","unstructured":"Ehrstr\u00f6m, M. C.: Das Adsorptionsverm\u00f6gen der Plasmaproteine. Acta med. scand.91, 191?196 (1937)","journal-title":"Acta med. scand."},{"issue":"Suppl. 3","key":"CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0773.1971.tb03293.x","volume":"29","author":"A. H. Anton","year":"1971","unstructured":"Anton, A. H., Corey, W. T.: Interindividual differences in the protein binding of sulfonamides: the effect of disease and drugs. Acta pharmacol. (Kbh.)29, (Suppl. 3) 134?151 (1971)","journal-title":"Acta pharmacol."},{"key":"CR15","first-page":"503","volume":"43","author":"G. Arango","year":"1968","unstructured":"Arango, G., Mayberry, W. E., Hockert, T. J., Elveback, L. R.: Total and free human serum thyroxine in normal and abnormal thyroid states. Mayo Clin. Proc.43, 503?516 (1968)","journal-title":"Mayo Clin. Proc."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00562320","volume":"8","author":"M. Ehrnebo","year":"1975","unstructured":"Ehrnebo, M., Odar-Cederl\u00f6f, I.: Binding of amobarbital, pentobarbital and diphyenylhydantoin to blood cells and plasma proteins in healthy volunteers and uremic patients. Europ. J. clin. Pharmacol.8, 445?453 (1975)","journal-title":"Europ. J. clin. Pharmacol."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cpt197518153","volume":"18","author":"K. O'Malley","year":"1975","unstructured":"O'Malley, K., Velasco, M. Pruitt, A., McNay, J. L.: Decreased plasma protein binding of diazoxide in uremia. Clin. Pharmacol. Ther.18, 53?58 (1975)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(70)91506-0","volume":"II","author":"I. Odar-Cederl\u00f6f","year":"1970","unstructured":"Odar-Cederl\u00f6f, I., Lunde, P., Sj\u00f6qvist, F.: Abnormal pharmacokinetics of phenytoin in a patient with uremia. Lancet1970 II, 831?832","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00567126","volume":"8","author":"M. Affrime","year":"1975","unstructured":"Affrime, M., Reidenberg, M. M.: The protein binding of some drugs in plasma from patients with alcoholic liver disease. Europ. J. clin. Pharmacol.8, 267?269 (1975)","journal-title":"Europ. J. clin. Pharmacol."},{"key":"CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1203\/00006450-197003000-00009","volume":"4","author":"M. S. Ebadi","year":"1970","unstructured":"Ebadi, M. S., Kugel, R. B.: Alteration in metabolism of acetylsalicylic acid in children with Down's syndrome: decreased plasma binding and formation of salicyluric acid. Pediat. Res.4, 187?193 (1970)","journal-title":"Pediat. Res."},{"key":"CR21","first-page":"83","volume":"44","author":"V. P. Tikhonow","year":"1972","unstructured":"Tikhonow, V. P.: Investigation of blood serum protein binding of salicylates in chronic circulatory insufficiency. Ter. Arkh.44, 83?86 (1972)","journal-title":"Ter. Arkh."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00000542-197310000-00015","volume":"39","author":"M. M. Ghoneim","year":"1973","unstructured":"Ghoneim, M. M., Kramer, S. E., Bannow, R., Pandya, H., Routh, J. I.: Binding ofd-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Anesthesiology39, 410?415 (1973)","journal-title":"Anesthesiology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jps.2600610530","volume":"61","author":"T. Tsuchiya","year":"1972","unstructured":"Tsuchiya, T., Levy, G.: Biotransformation of salicylic acid to its acyl and phenolic glucoronides in man. J. pharm. Sci.61, 800?801 (1972)","journal-title":"J. pharm. Sci."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI107865","volume":"54","author":"D. T. Lowenthal","year":"1974","unstructured":"Lowenthal, D. T., Briggs, W. A., Levy, G.: Kinetics of salicylate elimination by anephric patients. J. clin. Invest.54, 1221?1226 (1974)","journal-title":"J. clin. Invest."},{"key":"CR25","unstructured":"Reidenberg, M. M.: Personal communication (1976)"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/cpt1970116846","volume":"11","author":"P. K. Lunde","year":"1970","unstructured":"Lunde, P. K., Rane, A., Yaffe, S. J., Lund, L., Sj\u00f6qvist, F.: Plasma protein binding of diphenylhydantoin in man. Clin. Pharmacol. Ther.11, 846?855 (1970)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR27","unstructured":"Skuterud, B., Enger, E., Halvorsen, S., Jacobsen, S., Lunde, P. K. M.: Serum protein binding of quinidine and diphenylhydantoin in healthy human volunteers and in patients with chronic renal failure. Fifth Internat. Congr. Pharmacol. Abstracts of invited presentations, pp. 79?80. San Francisco 1972"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(75)90147-8","volume":"33","author":"O. G. Nilsen","year":"1975","unstructured":"Nilsen, O. G., Fremstad, D., Jacobsen, S.: Increased binding of quinidine to serum albumin and lipoproteins in anuric rats. Europ. J. Pharmacol.33, 131?139 (1975)","journal-title":"Europ. J. Pharmacol."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/cpt1975176677","volume":"17","author":"G. D. Olsen","year":"1975","unstructured":"Olsen, G. D., Bennet, W. M., Porter, G. A.: Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin. Pharmacol. Ther.17, 677?684 (1975)","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00606415\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00606415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T20:31:16Z","timestamp":1705350676000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00606415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1977]]}},"alternative-id":["BF00606415"],"URL":"https:\/\/doi.org\/10.1007\/bf00606415","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977]]}}}